Evidence map›Paper›PMID 38864138›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2024

[Clinicopathological characteristics of the CD8

Xiaodong Chai, Ziwen Sun, Haishuang Li, Liangyi Zhu, Xiaodan Liu, Yantao Liu, Fei Pei, Qing Chang

Abstract readEnglish Abstract
PubMed Full text at PMC
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaodong ChaiDepartment of Pathology, Peking University Third Hospital, Beijing 100191, China.
Ziwen SunDepartment of Pathology, Peking University Third Hospital, Beijing 100191, China.
Haishuang LiDepartment of Pathology, Peking University Third Hospital, Beijing 100191, China.
Liangyi ZhuDepartment of Pathology, Peking University Third Hospital, Beijing 100191, China.
Xiaodan LiuDepartment of Pathology, Peking University Third Hospital, Beijing 100191, China.
Yantao LiuDepartment of Pathology, Peking University Third Hospital, Beijing 100191, China.
Fei PeiDepartment of Pathology, Peking University Third Hospital, Beijing 100191, China.
Qing ChangDepartment of Molecular Neuropathology, Beijing Neurosurgical Institute, Beijing 100070, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the characteristics of the CD8

methodsIn the study, 48 clinical MB samples (12 cases in each of 4 subtypes) were selected from the multiple medical center from 2012 to 2019. The transcriptomics analysis for the tumor of 48 clinical samples was conducted on the NanoString PanCancer IO360

resultsThe characteristic index of CD8

conclusionThe CD8

Indexed as

CD8-Positive T-LymphocytesChemokine CXCL11MedulloblastomaReceptors, CXCR3Cerebellar NeoplasmsFemaleHumansLymphocytes, Tumor-InfiltratingMalePrognosisChemokine CXCL11CXCL11 protein, humanCXCR3 protein, humanReceptors, CXCR3CD8-positive T-lymphocytesChemokine CXCL11MedulloblastomaTumor microenvironment

Identifiers

PMID38864138
PMCPMC11167556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.